Dietary vitamin e and quercetin modulate inflammatory responses of collagen-induced arthritis in mice

Journal of Medicinal Food

Volumn 12, Issue 4, 2009, Pages 770-775

  Choi, Eun Jin ^a   Bae, Sang Cheol ^b   Yu, Rina ^c   Youn, Jeehee ^d   Sung, Mi Kyung ^a  

^a Sookmyung Women's University   (South Korea)

^b University of Ulsan   (South Korea)

^c Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

Antioxidants; Inflammation; Quercetin; Rheumatoid arthritis; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; COLLAGEN; INTERLEUKIN 1BETA; MACROPHAGE CHEMOATTRACTANT PROTEIN 1; MESSENGER RNA; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALPHA TOCOPHEROL DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; RISK FACTOR;

ALPHA-TOCOPHEROL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; COLLAGEN; CYTOKINES; DIET; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED DBA; QUERCETIN; RISK FACTORS; RNA, MESSENGER; VITAMIN E DEFICIENCY;

MUS;

EID: 70149110651     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.1246     Document Type: Article

References (32)

1. Wolfe, F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksei SM, Cathey MA: The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-494.
2. Goronzy JJ, Weyand CM: Rheumatoid arthritis. Immunol Rev 2004;204:55-73.
3. Shingu M, Nagai Y, Isayama T, Naono T, Nobunaga M, Nagai Y: The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Im-munol 1993;94:145-149.
4. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-2101.
5. Kamanli A, Nazirog lu M, Aydilek N, Hacievliyagil C: Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct 2004;22:53-57. (Pubitemid 38113621)
6. Bae S-C, Kim S-J, Sung M-K: Inadequate antioxidant nutrient intake and altered plasma antioxidant status of rheumatoid arthritis patients. J Am Coll Nutr 2003;22:311-315.
7. Fubini B, Hubbard A: Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflamma-tion and fibrosis. Free Radic Biol Med 2003;34:1507-1516.
8. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G: The NFkB-mediated control of ROS and JNK signaling. Histol His-topathol 2006;21:69-80.
9. Linos A, Kaklamanis E, Kontomerkos A, Koumantaki Y, Gazi S, Vaiopoulos G, Tsokos GC, Kaklamanis P: Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables. Am J Clin Nutr 1999;70:1077-1082.
10. American Institute of Nutrition: Second Report of the Ad Hoc Committee on Standard for Nutritional Studies. J Nutr 1980;110: 1726.
11. Yoon J, Lee KH, Won J, Huh SJ, Yun HS, Cho WG, Paik DJ: Beneficial effects of rosmarinic acid on suppression of collagen induced arthritis. J Rheumatol 2005;30:1203-1207.
12. Bubici C, Papa S, Denn K, Franzoso G: Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 2006;25: 6731-6748.
13. Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 2006;441:431-436.
14. O'Sullivan B, Thompson A, Thomas R: NF-kappa B as a therapeutic target in autoimmune disease. Expert Opin Ther Targets 2007;11:111-122.
15. Comstock GW, Burke AE, Hoffman SC, Heizlsouer KJ, Bendich A, Masi AT, Norkus EP, Malamet RL, Gershwin ME: Serum concentration of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1997;56:323-325.
16. Hein GE, Kohler M, Oelzner P, Stein G, Franke S: The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Rheuma-tol Int 2005;26:137-141.
17. Nowak D, Lewandowicz J, Dbkowska B, Marczak J: Combination of methotrexate and prednizone decreases circulating concentrations of interleukin 1 beta and interleukin 6 in patients with rheumatoid arthritis. Poor correlation of cytokine suppression with clinical improvements. Int J Immunopathol Pharmacol 1999;12:13-21.
18. Karouzakis E, Neidhard M, Gay RE, Gay S: Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 2006; 106:8-13. (Pubitemid 44093056)
19. Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, Gregory SA, Sakson PC: Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin-6 production in vivo. J Exp Med 1996;184:883-891.
20. Jung W-J, Sung M-K: Effects of major dietary antioxidants on inflammatory markers of RAW 264.7 macrophages. Biofactors 2004;21:113-117.
21. Singh U, Devaraj S, Jialal I: Vitamin E, oxidative stress and inflammation. Annu Rev Nutr 2005;25:151-174.
22. Devaraj S, Jialal I: Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler Thromb Vasc Biol 1999;19:1125-1133.
23. Edmonds S, Winyard P, Guo R, Kidd B, Merry P, Langrish-Smith A, Hansen C, Ramm S, Blake DR: Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheum Dis 1997;56:649-655.
24. Wittenborg A, Petersen G, Lorkowski G, Brabant T: Effectiveness of vitamin E in comparison with diclofenac sodium in treatment of patients with chronic polyarthritis. Z Rheumatol 1998;57:215-221.
25. De Bandt M, Grossin M, Driss F, Pincemail J, Babin-Chevaye C, Pasquier C: Vitamin E uncouples joint destruction and clinical inflammation in a transgenic model of rheumatoid arthritis. Arthritis Rheum 2002;46:522-532.
26. Venkatraman JT, Chu WC: Effects of dietary omega-3 and omega-6 lipids and vitamin E on serum cytokines, lipid mediators and anti-DNA antibodies in a mouse model of rheumatoid arthritis. J Am Coll Nutr 1999;18:602-613.
27. Fink VN, Steck SE, Wolff MS, Britton JA, Kabat GC, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD: Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 2006;165:514-523.
28. The Korean Nutrition Society: Dietary Reference Intakes for Koreans. Kook-Jin Planning, Seoul, 2005.
29. Min Y-D, Choi C-H, Bark H, Son H-Y, Park H-H, Lee S, Park J-W, Park E-K, Shin H-I, Kim S-H: Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res 2007;56: 210-215.
30. Mamani-Matsuda M, Kauss T, Al-Kharrat A, Rambert J, Fawaz F, Thiolat D, Moynet D, Coves S, Malvy D, Mossalayi MD: Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflamma-tory mediators. Biochem Pharmacol 2006;72:1304-1310.
31. Sato M, Miyazaki T, Kambe F, Maeda K, Seo H: Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and mono-cyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 1997; 24:1680-1684.
32. Sharma V, Mishra M, Ghosh S, Tewari R, Basu A, Seth P, Sen E: Modulation of interleukin-1beta mediated inflammatory response in human astrocyte by flavonoids: implications in neuroprotec-tion. Brain Res Bull 2007;73:55-63.